Human LRH-1/NR5A2 Antibody (H2325)

R&D Systems | Catalog # PP-H2325-00

R&D Systems
Loading...

Key Product Details

Species Reactivity

Validated:

Human

Cited:

Human, Mouse, Transgenic Mouse

Applications

Validated:

Western Blot, Direct ELISA, Immunoprecipitation

Cited:

Immunohistochemistry, Western Blot, Immunocytochemistry, Immunoprecipitation, Chromatin Immunoprecipitation (ChIP)

Label

Unconjugated

Antibody Source

Monoclonal Mouse IgG3 Clone # H2325
Loading...

Product Specifications

Immunogen

Recombinant human LRH-1/NR5A2
aa 161-280

Specificity

This antibody specifically recognizes human LRH-1 alpha and LRH-1 beta and cross-reacts with mouse and rat LRH-1. Not yet tested in other species.

Clonality

Monoclonal

Host

Mouse

Isotype

IgG3

Scientific Data Images for Human LRH-1/NR5A2 Antibody (H2325)

Detection of LRH-1/NR5A2 by Western Blot

Detection of LRH-1/NR5A2 by Western Blot

Effects of loss of LRH-1 on murine organoids. a Expression of mLRH-1 transcripts in intestinal organoids is widespread and higher in crypt regions (dashed black line). Scale bar = 100 μm. b Loss of mLRH-1 after Cre-recombination induced by 4-hydroxytamoxifen (4OHT) added to Lrh-1fl/fl;Vil-CreERT2 organoids for 48 h (Lrh1IEC-KO) compared to similarly treated wild-type (Lrh1fl/fl) organoids, as detected by anti-LRH-1 antibody. c Cell death in Lrh1fl/fl and Lrh1IEC-KO organoids following acute loss of Lrh-1. Values normalized to five independent wells of untreated Lrh1fl/fl organoids taken to be 0%. d Most significant gene changes up (blue) or down (ochre) after loss of mLRH-1 by RNA expression (q = < 0.05 and p = < 0.005). Gene names in bold refer to markers of differentiation while red refer to known EEC markers. e Top five altered gene networks as identified by IPA Ingenuity analysis. fLrh1fl/fl and Lrh1IEC-KO organoids exposed to TNF alpha (10 ng/ml) for 40 h stained for active Casp3 (red) and CD44 (green). Cells expressing active Casp3 undergoing cell death in crypt regions are indicated (white arrowheads and dashed white line). Scale bar = 50 μm. g Expression of active Casp3 in Lrh1fl/fl and Lrh1IEC-KO organoids as described in panel f, detected by western blotting (17 and19 kDa, black arrowheads). Shorter (top panel) and longer exposures (middle panel). h Uptake of fluorescent dextran after 30 min in Lrh1fl/fl and Lrh1IEC-KO organoids. Scale bar = 100 μm. Bar graph of percentage dye-positive enteroids (≥30 total organoids counted per condition). Data represent average of minimum three biological triplicates. For c and g, error bars are SEM using Student’s t test (unpaired, two tailed) with p values of ****p = < 0.0001 Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/30305617), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of LRH-1/NR5A2 by Immunocytochemistry/ Immunofluorescence

Detection of LRH-1/NR5A2 by Immunocytochemistry/ Immunofluorescence

Effects of dTF gene inactivation on acinar protein synthesis.A. Gene sets for protein synthesis pathways preferentially affected by dTF gene inactivation. B. Immunofluorescence detection of phosphorylated Rps6 and eIF4G in normal and dTF-cKO pancreases. Dashed outlines, normal acini; arrowheads, cells that escaped Ptf1a-deletion. C. Numbers of genes affected by the dTF-cKOs that associate with sub-processes of protein production. Parentheses: total number of genes in each category (see S2 Table); red inserts, number of Myc hallmark target genes. P, Ptf1a; N, Nr5a2, F, Foxa2; G, Gata4 cKOs. D. Rates of protein synthesis in short-term cultures of pancreatic lobules measured by incorporation of 35S-methionine/cysteine per μg DNA per minute (representative experiments for each cKO). Lines are the linear regression fits. E. Summary of all experiments measuring rates of protein synthesis for the dTF-cKOs. Numbers in bars are the number of mice for each genotype. Student’s t-test results with SD; ** p value <0.01. F. Changes of mRNA levels (RNA-seq) for key regulators of protein synthesis; no bar indicates values with an fdr >0.01. G-J. ChIP-seq profiles for the binding of the dTFs to four key target genes for protein synthesis. Shaded bars, ARDs. The grey gene fragments are the ends of neighboring genes: Mobkl2c and Kncn for Mknk1 and Mlh3 for Eif2b2. K. Regulatory and potential rate-limiting steps of acinar protein synthesis. Colored letters indicate which cKOs affected mRNA levels. Image collected and cropped by CiteAb from the following open publication (https://dx.plos.org/10.1371/journal.pone.0291512), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of LRH-1/NR5A2 by Immunohistochemistry

Detection of LRH-1/NR5A2 by Immunohistochemistry

Specialized PAC metabolism is maintained by the dTFs.A. The metabolic focus of acinar cells as judged by the enrichment of genes for particular metabolic functions in dTF-cKO pancreases and based on ConsensusPathDB analyses [69]. Filled bars, numbers of genes with decreased mRNA; open bars, numbers with increased mRNA. B. Quantification of the relative importance of metabolic gene control by the four dTFs. Total number of affected metabolism genes based on 1386 genes of KEGG metabolism, the percentage of affected genes, and the percent of total affected genes for each cKO that are classified for metabolic function. C. Differentially expressed genes of intermediary metabolism, with emphasis on genes affected by multiple dTF-cKOs. Asterisks, genes and proteins reported in panels D-H. D-G. Multiple dTF binding at active enhancers of key metabolic genes Ahcy, Gls2, Gatm and Gamt. The grey gene in panel E is Sprdy4. Shaded bars, ARDs. H. Immunodetection of cytosolic and nuclear Gamt (red); blue, nuclear DAPI. Dashed outline, acinus; arrowhead, Ptf1a-deletion escapee with nuclear and cytoplasmic Gamt. Image collected and cropped by CiteAb from the following open publication (https://dx.plos.org/10.1371/journal.pone.0291512), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of LRH-1/NR5A2 by Western Blot

Detection of LRH-1/NR5A2 by Western Blot

Loss of LRH-1 exacerbates acute liver injury triggered by CCl4 or APAP.(A) Western blotting analysis of total cell lysates or chromatin fractions from livers of Lrh-1hep+/+ and Lrh-1hep–/– mice treated or untreated with CCl4 for 24 hours. Quantification of blotting analysis showing the relative levels of ASNS protein compared with the loading control TUBULIN. (B) mRNA expression levels of Asns in CCl4-treated livers from (A). n = 6 (Lrh-1hep+/+ veh, Lrh-1hep–/– CCl4); n = 5 (Lrh-1hep–/– veh); and n = 7 (Lrh-1hep+/+ CCl4). (C) Serum ALT activity in mice from (B). (D) TUNEL assay in livers from (B). Scale bar: 100 μm. (E) mRNA analysis of livers from Lrh-1hep+/+ and Lrh-1hep–/– mice treated with or without APAP for 24 hours. n = 4 (Lrh-1hep+/+ veh, Lrh-1hep–/– veh); n = 6 (Lrh-1hep+/+ APAP); and n = 5 (Lrh-1hep–/– APAP). (F) ALT activity in serum and H&E staining in livers from mice in (E). Scale bar: 100 μm. Error bars denote SEM. Statistical analysis was performed by 2-way ANOVA followed by Bonferroni’s posthoc test (A–F). *P < 0.05; **P < 0.01; ***P < 0.001. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36719750), licensed under a CC-BY license. Not internally tested by R&D Systems.

Applications for Human LRH-1/NR5A2 Antibody (H2325)

Application
Recommended Usage

Direct ELISA

This antibody can be used at 2 ng/mL with the appropriate secondary reagents to detect human LRH-1.

Immunoprecipitation

Optimal dilutions should be determined by each laboratory.

Western Blot

This antibody can be used at 1 μg/mL with the appropriate secondary reagents to detect human LRH-1.

Formulation, Preparation, and Storage

Purification

Protein A or G purified from hybridoma culture supernatant

Formulation

A liquid formulation in physiologic saline with 0.1% NaN<sub>3</sub>.

Shipping

The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

This antibody is stable for greater than six months when held at -20 °C in a manual defrost freezer or at -70 °C. Upon thawing, the antibody can be stored at 2-8 °C for at least 1 month without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Background: LRH-1/NR5A2

Liver Receptor Homologous Protein (LRH-1, FTF, CPF, hB1F, FTZ-F1b; NR5A2) is a member of the Orphan Nuclear Receptor family. LRH-1 is a mammalian homolog of the Drosophila Fushi Tarazu F1 Gene product. LRH-1 is expressed in the liver and intestine. LRH-1 is involved in the regulation of genes which participate in steroid, bile acid and cholesterol homeostasis.

Long Name

Liver Receptor Homolog 1/Nuclear Receptor Subfamily 5, Group A, Member 2

Alternate Names

B1F2, FTZ-F1 beta, LRH1, NR5A2

Entrez Gene IDs

2494 (Human)

Gene Symbol

NR5A2

Additional LRH-1/NR5A2 Products

Product Documents for Human LRH-1/NR5A2 Antibody (H2325)

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Human LRH-1/NR5A2 Antibody (H2325)

For research use only

Citations for Human LRH-1/NR5A2 Antibody (H2325)

Customer Reviews for Human LRH-1/NR5A2 Antibody (H2325)

There are currently no reviews for this product. Be the first to review Human LRH-1/NR5A2 Antibody (H2325) and earn rewards!

Have you used Human LRH-1/NR5A2 Antibody (H2325)?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 for a review with an image

$10/€7/£6/$10CAN/¥1110 for a review without an image

Submit a review
Amazon Gift Card

FAQs

No product specific FAQs exist for this product.

View all FAQs for Antibodies
Loading...